Covishield is an India-made vaccine that has proved to be very effective in preventing coronavirus. France allowed travelers who have been vaccinated with Covishield into the country. This decision came immediately after a global concern over the fact that the European Union Covid-19 certificate recognizes AstraZeneca vaccines produced in Europe.
Several countries have approved the use of the Covishield vaccine among travelers. The European Union just introduced the “Green Pass” program. This program might enable travelers who have received an approved set of vaccines to travel around the 27-country zone of Europe.
It is indeed excellent news for travelers, as we see 16 European countries recognizing Covishield as an acceptable vaccine for entry. However, despite being vaccinated, entry guidelines might vary from country to country.Adar Poonawalla, Serum Institute of India’s CEO
You can also read: California’s Legislature to Approve Broadband Internet Bill
Countries such as Belgium, Finland, Ireland, Netherlands, Austria, Hungary, Bulgaria, Germany, Latvia, Greece, Spain, France, and Ukraine among others have approved Covishield for international travel.
India had started its vaccination drive this year. India has been making efforts to ensure Covaxin receives international approval and recognition. Covaxin is a vaccine manufactured by Bharat Biotech. After the Green Pass was introduced, a travel pass between EU nations for persons who received one of these four vaccines; Moderna, Comirnaty by Pfizer/BioNtech, Janssen by Johnson& Johnson, and Vaxzervria by AstraZeneca Oxford was approved.
This raised concerns in India. Covishield wasn’t included within the European green pass list despite this vaccine is the equivalent of AstraZeneca vaccine. The green card will ensure undisturbed travel across the 27 member countries of the EU.
EU countries don’t have to impose further travel restrictions such as compulsory quarantine, on travelers with a green pass. The green pass serves as a certificate of immunization. India has embraced member states of the EU to approve Covaxin and Covishield.